Cellenkos™, Inc. Announces FDA Clearance of Investigational New Drug Application for CK0801 for Bone Marrow Failure Syndromes
HOUSTON, June 10, 2018 /PRNewswire/ -- Cellenkos™, Inc., a clinical-stage biotechnology company, today announced that the United States Food and Drug Administration has cleared the Investigational New Drug (IND) application which allows for Cellenkos™ to proceed with a phase I clinical...
Source: PR Newswire Business Tech
Posted from my blog with SteemPress : https://networkurl.com/cellenkos-inc-announces-fda-clearance-of-investigational-new-drug-application-for-ck0801-for-bone-marrow-failure-syndromes-300663808-html